XML 102 R90.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidating Financial Information (Statements of Cash Flows) (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by operating activities $ 98,102 $ 122,426
Cash flows from investing activities:    
Sale of investment securities 12,942 2,647
Maturities of investment securities 28,610 10,598
Purchase of investment securities (44,222) (12,402)
Investments in real estate ventures (21,908) (4,343)
Acquisition of a business (668) (403)
Distributions from investments in real estate ventures 23,200 27,134
Increase in cash surrender value of life insurance policies (789) (809)
Decrease in restricted assets 668 262
Investments in subsidiaries 0 0
Proceeds from sale of fixed assets 8 0
Capital expenditures (6,320) (8,616)
Repayments of notes receivable 0 32
Pay downs of investment securities 545 928
Investments in real estate, net (1,153) (1,009)
Net cash (used in) provided by investing activities (9,087) 14,019
Cash flows from financing activities:    
Deferred financing costs (33) 0
Repayments of debt (230,771) (987)
Borrowings under revolver 172,224 134,310
Repayments on revolver (169,727) (137,877)
Capital contributions received 0 0
Intercompany dividends paid 0 0
Dividends and distributions on common stock (118,748) (112,462)
Distributions to non-controlling interest (285) (359)
Net cash used in financing activities (347,340) (117,375)
Net (decrease) increase in cash, cash equivalents and restricted cash (258,325) 19,070
Cash, cash equivalents and restricted cash, beginning of period 591,729 310,937
Cash, cash equivalents and restricted cash, end of period 333,404 330,007
Consolidating Adjustments    
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by operating activities (139,356) (115,340)
Cash flows from investing activities:    
Sale of investment securities 0 0
Maturities of investment securities 0 0
Purchase of investment securities 0 0
Investments in real estate ventures 0 0
Acquisition of a business 0 0
Distributions from investments in real estate ventures 0 0
Increase in cash surrender value of life insurance policies 0 0
Decrease in restricted assets 0 0
Investments in subsidiaries 27,482 6,790
Proceeds from sale of fixed assets 0  
Capital expenditures 0 0
Repayments of notes receivable   (20,000)
Pay downs of investment securities 0 0
Investments in real estate, net 0 0
Net cash (used in) provided by investing activities 27,482 (13,210)
Cash flows from financing activities:    
Deferred financing costs 0  
Repayments of debt 0 20,000
Borrowings under revolver 0 0
Repayments on revolver 0 0
Capital contributions received (27,482) (6,790)
Intercompany dividends paid 139,356 115,340
Dividends and distributions on common stock 0 0
Distributions to non-controlling interest 0 0
Net cash used in financing activities 111,874 128,550
Net (decrease) increase in cash, cash equivalents and restricted cash 0 0
Cash, cash equivalents and restricted cash, beginning of period 0 0
Cash, cash equivalents and restricted cash, end of period 0 0
Parent/Issuer | Reportable Legal Entities    
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by operating activities 78,661 88,944
Cash flows from investing activities:    
Sale of investment securities 12,942 2,647
Maturities of investment securities 28,610 10,598
Purchase of investment securities (44,222) (12,402)
Investments in real estate ventures 0 0
Acquisition of a business 0 0
Distributions from investments in real estate ventures 0 0
Increase in cash surrender value of life insurance policies (385) (408)
Decrease in restricted assets (15) 22
Investments in subsidiaries (27,482) (6,790)
Proceeds from sale of fixed assets 0  
Capital expenditures 0 (15)
Repayments of notes receivable   20,000
Pay downs of investment securities 545 928
Investments in real estate, net 0 0
Net cash (used in) provided by investing activities (30,007) 14,580
Cash flows from financing activities:    
Deferred financing costs 0  
Repayments of debt (230,000) 0
Borrowings under revolver 0 0
Repayments on revolver 0 0
Capital contributions received 0 0
Intercompany dividends paid 0 0
Dividends and distributions on common stock (118,748) (112,462)
Distributions to non-controlling interest 0 0
Net cash used in financing activities (348,748) (112,462)
Net (decrease) increase in cash, cash equivalents and restricted cash (300,094) (8,938)
Cash, cash equivalents and restricted cash, beginning of period 474,880 194,719
Cash, cash equivalents and restricted cash, end of period 174,786 185,781
Subsidiary Guarantors | Reportable Legal Entities    
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by operating activities 148,639 144,713
Cash flows from investing activities:    
Sale of investment securities 0 0
Maturities of investment securities 0 0
Purchase of investment securities 0 0
Investments in real estate ventures 0 0
Acquisition of a business 0 0
Distributions from investments in real estate ventures 0 0
Increase in cash surrender value of life insurance policies (404) (401)
Decrease in restricted assets 683 240
Investments in subsidiaries 0 0
Proceeds from sale of fixed assets 8  
Capital expenditures (2,753) (2,072)
Repayments of notes receivable   0
Pay downs of investment securities 0 0
Investments in real estate, net 0 0
Net cash (used in) provided by investing activities (2,466) (2,233)
Cash flows from financing activities:    
Deferred financing costs (33)  
Repayments of debt (621) (20,840)
Borrowings under revolver 172,224 134,310
Repayments on revolver (169,727) (137,877)
Capital contributions received 575 500
Intercompany dividends paid (102,739) (83,219)
Dividends and distributions on common stock 0 0
Distributions to non-controlling interest 0 0
Net cash used in financing activities (100,321) (107,126)
Net (decrease) increase in cash, cash equivalents and restricted cash 45,852 35,354
Cash, cash equivalents and restricted cash, beginning of period 23,849 20,175
Cash, cash equivalents and restricted cash, end of period 69,701 55,529
Subsidiary Non-Guarantors | Reportable Legal Entities    
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by operating activities 10,158 4,109
Cash flows from investing activities:    
Sale of investment securities 0 0
Maturities of investment securities 0 0
Purchase of investment securities 0 0
Investments in real estate ventures (21,908) (4,343)
Acquisition of a business (668) (403)
Distributions from investments in real estate ventures 23,200 27,134
Increase in cash surrender value of life insurance policies 0 0
Decrease in restricted assets 0 0
Investments in subsidiaries 0 0
Proceeds from sale of fixed assets 0  
Capital expenditures (3,567) (6,529)
Repayments of notes receivable   32
Pay downs of investment securities 0 0
Investments in real estate, net (1,153) (1,009)
Net cash (used in) provided by investing activities (4,096) 14,882
Cash flows from financing activities:    
Deferred financing costs 0  
Repayments of debt (150) (147)
Borrowings under revolver 0 0
Repayments on revolver 0 0
Capital contributions received 26,907 6,290
Intercompany dividends paid (36,617) (32,121)
Dividends and distributions on common stock 0 0
Distributions to non-controlling interest (285) (359)
Net cash used in financing activities (10,145) (26,337)
Net (decrease) increase in cash, cash equivalents and restricted cash (4,083) (7,346)
Cash, cash equivalents and restricted cash, beginning of period 93,000 96,043
Cash, cash equivalents and restricted cash, end of period $ 88,917 $ 88,697